Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 15 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 10758526

    Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  2. US 10758613

    Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  3. US 10736919

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  4. US 10729725

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  5. US 10730925

    Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

    Protalix Ltd. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  6. US 10722540

    Microfluidic device and method for shear stress-induced transformation of cells

    The Regents of the University of California · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  7. US 10722537

    Activation of resident memory T cells for cancer immunotherapy

    Regents of the University of Minnesota · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  8. US 10716809

    Methods of producing enriched populations of tumor reactive T cells from peripheral blood

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  9. US 10702628

    Hyaluronic acid derivative and neural stem cells for SCI and PNT regeneration

    Anika Therapeutics S.r.l. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  10. US 10696945

    Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells

    China Medical University · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  11. US 10683354

    Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  12. US 10675307

    Compositions comprising perivascular stem cells and nell-1 protein

    The Regents of the University of California · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  13. US 10675267

    Methods for detection and eradication of myeloid leukemia stem cells

    The Regents of the University of California · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  14. US 10655103

    Equine progenitor cells

    University College Cardiff Consultants Limited · Granted May 19, 2020 · Expires May 14, 2040

    granted

  15. US 10633451

    Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine

    Ludwig-Maximilians-Universitat Munchen · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  16. US 10633432

    VC-CAR molecule and use thereof in removing HIV-1 infected cells

    Shenzhen City of Regeneration Biological Pharmaceutical Technology Co., Ltd. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  17. US 10633643

    Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  18. US 10611998

    Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

    The Regents of the University of California · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  19. US 10596275

    Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

    Aura Biosciences, Inc. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  20. US 10583200

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  21. US 10583202

    Homologous recombination in multipotent adult progenitor cells

    Regents of the University of Minnesota · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  22. US 10578608

    Tools to detect, track and target cancer cells in vivo

    The Regents of the University of California · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted

  23. US 10568913

    Method for generating mature β-like cells

    Healthregen PTY LTD · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  24. US 10564149

    Populations of mesenchymal stem cells that secrete neurotrophic factors

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.